初始血液透析血管通路结局:隧道导管起始透析患者的研究
基于Optum数据库2011-2017年8941例以隧道导管起始透析的患者,比较初始AVF与AVG对导管移除时间、重复通路创建概率及时间的影响。AVG较AVF显著缩短导管移除时间,且年龄≥70岁差异更大;AVG与更低重复通路概率和更长重复通路时间相关。
要点
- AVG较AVF显著缩短隧道导管移除时间,年龄≥70岁差异更大。
- 初始AVG与更低重复通路创建概率和更长重复通路时间相关。
- 「内瘘优先」不适用于所有患者,支持审慎使用AVG以实现「导管最后」。
核心结论
- AVG较AVF显著缩短透析依赖患者隧道导管移除时间,年龄≥70岁差异更大。
- 初始AVG与更低重复血管通路创建概率和更长重复通路时间相关。
- 「内瘘优先」并非适用于所有患者,支持审慎使用AVG以实现「导管最后」。
研究设计与样本
- 回顾性队列研究,查询Optum Clinformatics Data Mart理赔数据库2011-2017年以隧道导管起始透析的患者。
- 共8941例血管通路符合纳入标准:AVF 6913例(77%),AVG 2028例(23%)。
- AVF患者中位随访595天(范围1-2543天),AVG患者中位随访579天(范围1-2529天)。
- 采用Cox比例风险模型分析导管移除时间和重复通路时间,逻辑回归分析重复通路可能性。
主要发现
- AVF患者更年轻、男性比例更高、白人比例更高、肥胖比例更高,糖尿病、心律失常、充血性心力衰竭和外周血管疾病比例略低。
- 指数通路创建后90天和180天,AVG组导管移除患者显著多于AVF组;365天时两组均为78%移除导管。
- 随访期间2550例(28.5%)患者接受重复血管通路创建:初始AVF组30%,初始AVG组24%。
- 90天、180天和365天时,初始AVF组重复血管通路创建患者显著多于AVG组。
- 多变量分析显示通路类型与年龄≥70岁存在显著交互作用(P < .001),影响导管移除时间、重复通路可能性和重复通路时间。
关键数值与推荐
- 年龄<70岁组:AVG较AVF缩短导管移除时间的可能性高60%,重复通路几率低50.4%,重复通路时间延长的可能性高47%。
- 年龄≥70岁组:AVG较AVF缩短导管移除时间的可能性高98%,重复通路几率低69.7%,重复通路时间延长的可能性高66%。
临床怎么用
- 对于以隧道导管起始透析的患者,尤其年龄≥70岁,可考虑优先创建AVG以加速导管移除。
- 初始AVG可能降低重复通路创建需求并延长重复通路时间,支持个体化通路规划。
- 不应机械遵循「内瘘优先」,应结合患者年龄等因素审慎选择AVG以实现「导管最后」。
局限性
- 回顾性理赔数据库研究,可能存在编码偏倚和未测量混杂因素。
- 仅纳入以隧道导管起始透析的患者,结论外推需谨慎。
- 缺乏通路失败、并发症及患者生存等详细临床结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our aim was to determine factors that influence time to removal of tunneled hemodialysis catheter (THC), probability of repeat vascular access creation, and time to repeat vascular access. METHODS: The Optum Clinformatics Data Mart claims database was queried from 2011 to 2017 for patients who initiated hemodialysis with a THC. Time from initial arteriovenous fistula (AVF)/graft (AVG) to THC removal and time to repeat AVF/AVG were analyzed using Cox proportional hazards. The likelihood of repeat AVF/AVG was analyzed using logistic regression. RESULTS: A total of 8941 vascular access met the inclusion criteria: 6913 (77%) AVF and 2028 (23%) AVG. Median follow-up was 595 days among AVF patients (range, 1-2543 days) and 579 days among AVG patients (range, 1-2529 days). Patients undergoing AVF were younger, more likely to be male, of white race, and obese. Patients undergoing AVF were also slightly less likely to have diabetes, cardiac arrhythmia, congestive heart failure, and peripheral vascular disease than patients undergoing AVG. At 90 days and at 180 days after index access creation, significantly more patients who underwent index AVG had their THC removed compared with patients who underwent index AVF. By day 365, 78% of patients in both AVF and AVG had their THC removed. A total of 2550 (28.5%) patients underwent a repeat vascular access creation during the follow-up period: 30% of index AVF and 24% of index AVG. At 90 days, 180 days, and 365 days, significantly more patients in the index AVF group underwent a repeat vascular access creation than those in the index AVG group. Multivariate analysis demonstrated a significant interaction between vascular access type and age ≥70 years (P < .001) for time to THC removal, likelihood of repeat vascular access, and time to repeat vascular access. In the age <70 group, patients who underwent AVG were 60% more likely to have a shorter time to THC, had a 50.4% lower odds of repeat vascular access, and were 47% more likely to have a longer time to repeat vascular access compared with patients who underwent index AVF. In the age ≥70 group, patients who underwent AVG were 98% more likely to have a shorter time to THC removal, had 69.7% lower odds of repeat vascular access, and were 66% more likely to have a longer time to repeat vascular access. CONCLUSIONS: Creation of AVG vs AVF significantly decreases the time to THC removal in dialysis-dependent patients, with a larger difference in patients aged ≥70 vs <70. Initial AVG was associated with lower odds of repeat vascular access and longer time to repeat vascular access. These results suggest that the dictum of "fistula first" is not appropriate for all patient populations and supports judicious use of AVG in achieving the more recent shift toward "catheter last."
引用
- Copeland T, Lawrence P, Woo K, et al. Outcomes of initial hemodialysis vascular access in patients initiating dialysis with a tunneled catheter. J Vasc Surg. 2019. PMID: 31147122. doi:10.1016/j.jvs.2019.02.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。